Furthermore, their studies have demonstrated that p53 deletion not only promotes NSCLC cell proliferation but also leads to a decrease in the expression of NKG2D ligands, rendering cancer cells more likely to evade recognition by NK cells and undergo immune evasion (15). The gene discussed is TP53; the disease is cancer.